Research Article

An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy

Volume: 7 Number: 2 July 21, 2025
EN TR

An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy

Abstract

Objective: This study aimed to evaluate the frequency and clinical characteristics of allergic reactions following Measles-Mumps-Rubella (MMR) vaccination in children with egg allergy. Our aim in selecting the MMR vaccine was to better understand vaccine-related allergic reactions in children with egg allergy and to assess its reliability. Material and Method: A retrospective analysis was conducted on 202 patients diagnosed with egg allergy who received the MMR vaccine in our clinic between 2023 and 2024. Demographic, clinical, and laboratory data were reviewed. Patients’ age, sex, concomitant allergic diseases, total IgE, specific IgE for milk, egg, and nuts, skin prick tests, and post-vaccination reactions were recorded. Results: The median age of the patients was 12 months (range: 7-84 months), and 57.4% were male. Sensitization to cow’s milk was detected in 29.2% of the patients, while 6.9% had nut allergen sensitivity. The most common clinical conditions were urticaria (43.1%) and atopic dermatitis (36.6%). Following vaccination, only four patients (2%) developed localized rash, and none had a history of anaphylaxis. Conclusion: No severe systemic reactions were observed following MMR vaccination in children with egg allergy. Our findings support current guidelines, suggesting that MMR vaccination can be safely administered under standard conditions in children with egg allergy. In our study, 29.2% of patients with egg allergy had cow’s milk allergy, and 6.9% had nut allergy, suggesting that food allergies are often seen together in childhood. Additionally, it is emphasized that the India-made MMR vaccines used in Turkey contain milk proteins, which may increase the risk of anaphylaxis in individuals with milk and egg allergies, highlighting the need for careful evaluation of the vaccine prospectus before vaccination in these children.

Keywords

References

  1. Burks AW, Tang M, Sicherer S, Wood R, Assa’ad A, Jones SM, et al. ICON: food allergy. J Allergy Clin Immunol. 2012;129(4):906-920.
  2. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025.
  3. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133(2):291-307.
  4. Chafen JJS, Newberry SJ, Riedl MA, Bravata DM, Maglione M, Suttorp MJ, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010;303(18):1848-1856.
  5. Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120(3):638-646.
  6. Tedner SG, Asarnoj A, Thulin H, Westman M, Konradsen JR, Nilsson C. Food allergy and hypersensitivity reactions in children and adults: A review. J Intern Med. 2022;291(3):283-302.
  7. Magistà S, Albanesi M, Chaoul N, Di Bona D, Di Leo E, Nettis E, et al. Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management. Clin Mol Allergy. 2020;18:1-5.
  8. Urisu A, Kondo Y, Tsuge I. Hen’s egg allergy. Chem Immunol Allergy. 2015;101:124-130.

Details

Primary Language

English

Subjects

Allergy

Journal Section

Research Article

Early Pub Date

July 17, 2025

Publication Date

July 21, 2025

Submission Date

February 24, 2025

Acceptance Date

April 11, 2025

Published in Issue

Year 2025 Volume: 7 Number: 2

APA
Alkaya, H., Altaş, U., Çevik, S., Altaş, Z. M., & Özkars, M. Y. (2025). An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy. Phoenix Medical Journal, 7(2), 74-77. https://doi.org/10.38175/phnx.1646261
AMA
1.Alkaya H, Altaş U, Çevik S, Altaş ZM, Özkars MY. An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy. Phnx Med J. 2025;7(2):74-77. doi:10.38175/phnx.1646261
Chicago
Alkaya, Halil, Uğur Altaş, Seda Çevik, Zeynep Meva Altaş, and Mehmet Yaşar Özkars. 2025. “An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children With Egg Allergy”. Phoenix Medical Journal 7 (2): 74-77. https://doi.org/10.38175/phnx.1646261.
EndNote
Alkaya H, Altaş U, Çevik S, Altaş ZM, Özkars MY (July 1, 2025) An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy. Phoenix Medical Journal 7 2 74–77.
IEEE
[1]H. Alkaya, U. Altaş, S. Çevik, Z. M. Altaş, and M. Y. Özkars, “An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy”, Phnx Med J., vol. 7, no. 2, pp. 74–77, July 2025, doi: 10.38175/phnx.1646261.
ISNAD
Alkaya, Halil - Altaş, Uğur - Çevik, Seda - Altaş, Zeynep Meva - Özkars, Mehmet Yaşar. “An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children With Egg Allergy”. Phoenix Medical Journal 7/2 (July 1, 2025): 74-77. https://doi.org/10.38175/phnx.1646261.
JAMA
1.Alkaya H, Altaş U, Çevik S, Altaş ZM, Özkars MY. An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy. Phnx Med J. 2025;7:74–77.
MLA
Alkaya, Halil, et al. “An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children With Egg Allergy”. Phoenix Medical Journal, vol. 7, no. 2, July 2025, pp. 74-77, doi:10.38175/phnx.1646261.
Vancouver
1.Halil Alkaya, Uğur Altaş, Seda Çevik, Zeynep Meva Altaş, Mehmet Yaşar Özkars. An Anatomy of a Fear: Clinical Outcomes of Measles-Mumps-Rubella Vaccination in Children with Egg Allergy. Phnx Med J. 2025 Jul. 1;7(2):74-7. doi:10.38175/phnx.1646261

2392_ccby-295.jpg
Phoenix Medical Journal is licensed under a Creative Commons Attribution 4.0 International License.


2392_boai-189.jpg

Phoenix Medical Journal has signed the Budapest Open Access Declaration.